An interventional study of Immediate application of the Smart Homespital system and Delayed application of the Smart Homespital system after 3 months in Interstitial Lung Disease, sponsored by Yonsei University. Active, not recruiting at 1 site in South Korea. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-07-07.
Sponsored by Yonsei University · Not applicable, Interventional, and Health services research
This study aims to analyze the effectiveness/safety/cost of the Smart Homespital system that provides a service that allows patients with interstitial lung disease to easily access and use biosignals generated using biosignal collection medical equipment at home.
646 studies on the registry are indexed under Lung Diseases, Interstitial; 237 are open to participants now.
This study's enrollment of 83 is above the median of 54 across 355 interventional studies indexed under Lung Diseases, Interstitial.
Browse Lung Diseases, Interstitial studies →Yonsei University is the lead sponsor of 1,387 studies on the registry; 232 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients diagnosed with COPD who meet the following pulmonary function test results:
Exclusion Criteria:
The Smart Homespital system can be applied for the first 3 months (12 weeks), and then the primary and secondary variables will be evaluated at 3, 6, 9months.
Behavioral: Immediate application of the Smart Homespital system
The waiting list-control group will receive general medical services for the first 3 months and will receive the Smart Homespital system for 3-6 months. Primary and secondary variables will be evaluated between 3, 6, and 9 months.
Behavioral: Delayed application of the Smart Homespital system after 3 months
The Smart Homespital system can be applied for the first 3 months (12 weeks), and then the primary and secondary variables will be evaluated at 3, 6, 9months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks.
The waiting list-control group will receive general medical services for the first 3 months and will receive a Smart Homespital system for 3-6 months. Primary and secondary variables will be monitored between 3, 6, and 9 months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks.
Respiratory symptom questionnaire
For survey scores, success is defined as an increase in the respective defined MCID(the minimal clinically important difference) rises the baseline. 1\) Chronic respiratory questionnaire (CRQ) * Success: 4 points or more 2.)Modified Medical Research Council dyspnea scale (mMRC) * Success: 1points or more 3) EQ-5D * Success: 1 points or more
Time frame: After applying the Smart Homespital system(12weaks)
Depression Questionnaire
K-CESD-R : Survey every 2 weeks during the 12-week Homespital system application, then at 3, 6, and 9 months after the start of the study. * Success Criteria: Achieving 4 points or more. * Success: 4 points or more
Time frame: Survey every 2 weeks during the 12-week Homespital system application, then at 3, 6, and 9 months after the start of the study.
Service satisfaction evaluation
* CSQ-8: After 12 weeks of applying the Smart Homespital system. * Success Criteria: Achieving 4 points or more.
Time frame: After 12 weeks of applying the Smart Homespital system.
safety
* Number of hospital visits directly related to the Smart Home Hospital Program * Success Criteria: Less than 2 hospital visits related to the Smart Homespital program.
Time frame: Measured after the study ends (9 months later).
cost assessment
\- Criteria: Comparison of average hospital respiratory rehabilitation treatment costs with the Smart Homespital program's costs.
Time frame: After study ends (9 months later)
6 minute walking test
\- Success Criteria: More than a 10% increase over the baseline.
Time frame: At 3, 6, and 9 months.
pulmonary function test
\- Success Criteria: Increase in FVC, FEV1, or DLCO by more than 10% at the time of registration.
Time frame: At 3, 6, and 9 months.
system compliance
-Criteria: Maintaining a minimum of 5,000 steps/day during the 12-week period of applying the Homespital system.
Time frame: During the 12-week period of applying the Homespital system.
This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yonsei University